BioNews (180610)
Courtesy of GEN News.
June 17, 2010, 10:19 AM EST
Qiagen Expands Partnership with Genome Diagnostics for Development of Six New HLA Tests
New sequencing-based portfolio will include assay for gene involved in lumiracoxib toxicity.
June 17, 2010, 10:30 AM EST
Teva and Clal Invest $17.5M in Andromeda to Fund Phase III Trial in Type 1 Diabetes
Study will evaluate if the synthetic Hsp60 peptide can maintain pancreas’ ability to secrete insulin.
June 17, 2010, 10:42 AM EST
Bayer Pays OncoMed $40M to Develop Drugs Targeting Cancer Stem Cells
Multimillion-dollar partnership covers antibodies, protein therapies, and small molecules.
June 17, 2010, 11:00 AM EST
FDA Partially Lifts Clinical Hold on Merck Serono’s Anticancer Vaccine
Stimuvax will resume in NSCLC Phase III trials, but the breast cancer study remains halted.
June 17, 2010, 11:11 AM EST
UC San Diego and Salk Institute to Conduct Cell Transplant Research for ALS with $11.5M
Life Technologies’ primary and stem cell systems business will be tapped.
June 16, 2010, 10:50 AM EST
Gladstone and Institute for Systems Biology to Conduct Whole-Genome Sequencing in Huntington Disease
Partners will look for genes related to onset and progression as well as drug targets.
June 16, 2010, 10:41 AM EST
Abbott Pays $75M to Develop Neurocrine’s GnRH Antagonists in Women’s and Men’s Health
Deal includes Phase II molecule for endometriosis and up to $500 million in milestones.
June 16, 2010, 10:32 AM EST
Predictive Biosciences Secures $25M to Push On with Bladder Cancer Test
Funding will also support expansion through recently acquired CLIA-certified lab.
June 15, 2010, 10:38 AM EST
AMRI Takes Over Hyaluron for $27M
Firm will now be able to offer sterile fill and finish services for small molecules and biologics.
June 14, 2010, 10:32 AM EST
Scientists Find Link Between ARB Therapy and Cancer
Research appearing in The Lancet Oncology suggests that those receiving one year of treatment have a 1.2% risk.
